All posts tagged "Gilead Sciences Inc."

• 

  16.5K

  2

  Biotech

  Wading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)

  CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...

• 

  29.8K

  1

  Biotech

  CytoDyn’s (OTCMKTS: CYDY) Strong Safety Data in Mild to Moderate Smokes Gilead (NASDAQ: GILD) & Crushes Endpoint Leading to the First Potential COVID-19 Approval

  CytoDyn Inc. (OTCMKTS: CYDY) announced groundbreaking safety results from its phase 2 Mild to Moderate COVID-19 trial today.  The company reported a...

• Stocks

  Today’s Hot List: Gilead Sciences Inc. (NASDAQ:GILD), CorMedix, Inc. (NYSEMKT:CRMD), Public Storage (NYSE:PSA), Eros International Plc (NYSE:EROS), Yingli Green Energy Holding (NYSE:YGE)

  Gilead Sciences Inc. (NASDAQ:GILD) on Nov 11, said its new Harvoni drug for hepatitis C achieved cure rates of 96 percent to...

• Stocks

  Top News: Petroleo Brasileiro Petrobras (NYSE:PBR), Gilead Sciences Inc. (NASDAQ:GILD), Rudolph Technologies Inc. (NYSE:RTEC), Superior Energy Services, (NYSE:SPN), Invesco Mortgage Capital (NYSE:IVR)

  Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) announces that its consolidated oil and gas production, in Brazil and abroad, reached 2 million 795...

• Stocks

  Investors Watch List: Gilead Sciences Inc. (NASDAQ:GILD), American Realty Capital Properties, Inc. (NASDAQ:ARCP), Old Point Financial Corporation (NASDAQ:OPOF), Tompkins Financial (NYSEMKT:TMP), AGNC

  Gilead Sciences (NASDAQ:GILD)‘s stock had its “positive” rating reaffirmed by research analysts at Robert W. Baird in a report released on Monday....

• Stocks

  Why Need to Watch: Gilead Sciences Inc. (NASDAQ:GILD), Solazyme (NASDAQ:SZYM), Universal Health Realty Income Trust (NYSE:UHT), Isis Pharmaceuticals (NASDAQ:ISIS), DreamWorks Animation (NASDAQ:DWA)

  Johnson & Johnson (JNJ) won U.S. approval for its hepatitis C drug Olysio to be used in combination with Gilead Sciences Inc....

• Stocks

  Investors Are Watching: Itau Unibanco Holding SA (ADR) (NYSE:ITUB), Gilead Sciences Inc. (NASDAQ:GILD), Eni SpA (NYSE:E), Stanley Furniture Co. Inc. (NASDAQ:STLY), DSCO

  Itau Unibanco Holding SA (ADR) (NYSE:ITUB), Brazil’s second-largest bank by assets, on Tuesday reported a 35% increase in third-quarter profit and said...

• Stocks

  Trader’s Recap: Gilead Sciences Inc. (NASDAQ:GILD), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Valley National Bancorp (NYSE:VLY), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Corcept Therapeutics Incorporated (NASDAQ:CORT)

  Gilead Sciences Inc. (NASDAQ:GILD) on Oct. 28 reported third-quarter profit of $2.73 billion. On a per-share basis, the company said it had...

• Stocks

  Hot News: Gilead Sciences Inc. (NASDAQ:GILD), BP p.l.c. (NYSE:BP), RealNetworks Inc. (NASDAQ:RNWK), Financial Engines, Inc. (NASDAQ:FNGN), 3D Systems Corporation (NYSE:DDD)

  Equities research analysts at Edward Jones started coverage on shares of Gilead Sciences (NASDAQ:GILD) in a research note issued to investors on...

• Stocks

  Hot News: Gilead Sciences Inc. (NASDAQ:GILD), The Coca-Cola Company (NYSE:KO), Thoratec Corp. (NASDAQ:THOR), Research Frontiers Inc. (NASDAQ:REFR), Cabela’s Incorporated (NYSE:CAB)

  Gilead Sciences Inc. (NASDAQ:GILD)’s EVP Paul Rutherford Carter sold 2,000 shares of Gilead Sciences stock on the open market in a transaction...